9 June 2026 - The Netherlands has postponed the launch of a revamped system for determining which new medicines will be covered by health insurers by six months, as patients already face some of the longest drug access delays in Europe.

Health Minister Sophie Hermans confirmed in a letter to parliament on 28 May that the so-called Future-Proof Medicines System – known by its Dutch acronym TSG – will not come into force until January 2028, following a request from the Dutch Healthcare Institute (Zorginstituut Nederland) to extend the original July 2027 deadline.

Read Euractiv article